Zaloguj się

Gotowe bibliografie tematyczne / Treatment outcome / Artykuły w czasopismach

Artykuły w czasopismach na temat „Treatment outcome”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Treatment outcome.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 30 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Treatment outcome”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Bloom, Bernard L. "Brief Interventions for Anxiety Disorders: Clinical Outcome Studies". Brief Treatment and Crisis Intervention 2, nr 4 (1.12.2002): 325–40. http://dx.doi.org/10.1093/brief-treatment/2.4.325.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Bloom, Bernard L. "Brief Psychotherapy With Children and Adolescents: Recent Treatment Outcome Studies". Brief Treatment and Crisis Intervention 2, nr 3 (1.09.2002): 261–74. http://dx.doi.org/10.1093/brief-treatment/2.3.261.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Ammini, Ariachery, Saptarshi Bhattacharya, Jaya Praksh Sahoo, Jim Philip, Nikhil Tandon, Ravinder Goswami, Viveka Jyotsna i in. "Cushing's disease: Results of treatment and factors affecting outcome". HORMONES 10, nr 3 (15.07.2011): 222–29. http://dx.doi.org/10.14310/horm.2002.1312.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Legrand, C., R. Sylvester, L. Duchateau, P. Janssen i P. Therasse. "Treatment outcome studies". European Journal of Cancer 38, nr 9 (czerwiec 2002): 1173–80. http://dx.doi.org/10.1016/s0959-8049(02)00085-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Alemi, Farrokh, Richard C. Stephens, Shirley Llorens i Benjamin Orris. "A Review of Factors Affecting Treatment Outcomes: Expected Treatment Outcome Scale". American Journal of Drug and Alcohol Abuse 21, nr 4 (styczeń 1995): 483–509. http://dx.doi.org/10.3109/00952999509002712.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Bloom, Bernard L. "Planned Short‐Term Psychotherapy for Depression: Recent Controlled Outcome Studies". Brief Treatment and Crisis Intervention 1, nr 2 (1.09.2001): 169–89. http://dx.doi.org/10.1093/brief-treatment/1.2.169.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Hørsted-Bindslev, Preben, i Henrik Løvschall. "Treatment outcome of vital pulp treatment". Endodontic Topics 2, nr 1 (lipiec 2002): 24–34. http://dx.doi.org/10.1034/j.1601-1546.2002.20103.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Graber, T. M. "Orthodontics: Treatment Need and Treatment Outcome". American Journal of Orthodontics and Dentofacial Orthopedics 113, nr 2 (luty 1998): A1. http://dx.doi.org/10.1016/s0889-5406(98)70152-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Malhotra, Parveen, Vani Malhotra, Yogesh Sanwariya, Ajay Chugh, Isha Pahuja i Akshay Akshay. "Acute HBV Related ALF- Successful Outcome with Oral Antiviral Treatment". Clinical Research and Clinical Trials 5, nr 1 (7.01.2022): 01–03. http://dx.doi.org/10.31579/2693-4779/069.

Pełny tekst źródła

Streszczenie:

Case report: We present a young female of fourteen years who was admitted to the hospital with short duration of Icterus, malaise, vomiting and diagnosed to be having acute hepatitis B. She went into acute liver failure as evidenced by development of hepatic encephalopathy and coagulopathy. She was managed on lines of hepatic encephalopathy along with oral antiviral treatment. She recovered successfully and was discharged after two weeks in heamodynamically stable condition. After a gap of six months, she became Hepatitis B surface (HbsAg) & hepatitis B e-antigen (HbeAg) negative and Hepatitis B Virus DNA (HBV DNA) was undetectable with normal liver function tests. She is on regular follow up for last one year and is absolutely normal. Conclusion: Acute hepatitis B can go into acute liver failure in 1% of cases, treatment for which includes liver transplantation and oral antiviral treatment which is especially helpful in cases who cannot afford liver transplantation, as was in our case.

Style APA, Harvard, Vancouver, ISO itp.

10

Schlesinger, Michael H., Ilene F. Wilets i Harris M. Nagler. "TREATMENT OUTCOME AFTER VARICOCELECTOMY". Urologic Clinics of North America 21, nr 3 (sierpień 1994): 517–29. http://dx.doi.org/10.1016/s0094-0143(21)00624-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Tabata, Takahisa, Takuro Kitamura, Nobusuke Hohchi, Yasuhiro Kise, Rintaro Kawaguchi, Fumiko Takenaga i Hideaki Suzuki. "Treatment Outcome of Myringoplasty". Practica Oto-Rhino-Laryngologica 110, nr 9 (2017): 593–97. http://dx.doi.org/10.5631/jibirin.110.593.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Gossop, M. "Addiction: Treatment and Outcome". Journal of the Royal Society of Medicine 85, nr 8 (sierpień 1992): 469–72. http://dx.doi.org/10.1177/014107689208500815.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Tabata, Takahisa, Takuro Kitamura, Nobusuke Hohchi, Yasuhiro Kise, Rintaro Kawaguchi, Fumiko Takenaga i Hideaki Suzuki. "Treatment Outcome of Myringoplasty". Practica oto-rhino-laryngologica. Suppl. 152 (2018): 22–23. http://dx.doi.org/10.5631/jibirinsuppl.152.22.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Keane, Aida. "Narratives of Treatment Outcome". Journal of Constructivist Psychology 29, nr 4 (24.02.2016): 382–95. http://dx.doi.org/10.1080/10720537.2015.1134365.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Pratt, Sarah I. "Introduction to Treatment Outcome". Residential Treatment For Children & Youth 13, nr 4 (25.07.1996): 1–27. http://dx.doi.org/10.1300/j007v13n04_01.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

HAVENS, LESTON, i MEREDITH FIELDS. "Schizophrenia: Treatment, Process, Outcome". American Journal of Psychiatry 147, nr 2 (luty 1990): 248. http://dx.doi.org/10.1176/ajp.147.2.248.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Blotcky, Mark J., i Thomas L. Dimperio. "Outcome of Inpatient Treatment". Journal of the American Academy of Child & Adolescent Psychiatry 30, nr 3 (maj 1991): 507. http://dx.doi.org/10.1097/00004583-199105000-00025.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Mirin, Steven M., i M. Jo Namerow. "Why Study Treatment Outcome?" Psychiatric Services 42, nr 10 (październik 1991): 1007–13. http://dx.doi.org/10.1176/ps.42.10.1007.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Hastings, Margaret. "Outcome for Stroke Treatment". Physiotherapy 80, nr 9 (wrzesień 1994): 649. http://dx.doi.org/10.1016/s0031-9406(10)60902-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Holland, Katherine D., i Elaine Wyllie. "Outcome after surgical treatment". Neurosurgery Clinics of North America 13, nr 1 (styczeń 2002): 135–44. http://dx.doi.org/10.1016/s1042-3680(02)80013-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Pancherz, Hans. "Treatment timing and outcome". American Journal of Orthodontics and Dentofacial Orthopedics 121, nr 6 (czerwiec 2002): 559. http://dx.doi.org/10.1067/mod.2002.124165.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Wilson, G. Terence. "Treatment outcome in Bulimia". Advances in Behaviour Research and Therapy 11, nr 3 (styczeń 1989): 161–74. http://dx.doi.org/10.1016/0146-6402(89)90020-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Kvittingen, E. A. "Tyrosinaemia ? treatment and outcome". Journal of Inherited Metabolic Disease 18, nr 4 (1995): 375–79. http://dx.doi.org/10.1007/bf00710049.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Rogers, Richard. "Treatability and treatment outcome". Behavioral Sciences & the Law 6, nr 4 (1988): 441–42. http://dx.doi.org/10.1002/bsl.2370060402.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Beutler, Larry E., Rudolf H. Moos i Geoffrey Lane. "Coping, treatment planning, and treatment outcome: Discussion". Journal of Clinical Psychology 59, nr 10 (2003): 1151–67. http://dx.doi.org/10.1002/jclp.10216.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

P, Dr Veena. "Fungal Keratitis – Epidemiology and Treatment Outcome - In North Costal Andhra Pradesh". Journal of Medical Science And clinical Research 05, nr 05 (6.05.2017): 21486–97. http://dx.doi.org/10.18535/jmscr/v5i5.43.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Sanislow, Charles A., i Thomas H. McGlashan. "Treatment Outcome of Personality Disorders". Canadian Journal of Psychiatry 43, nr 3 (kwiecień 1998): 237–50. http://dx.doi.org/10.1177/070674379804300302.

Pełny tekst źródła

Streszczenie:

Objective: To review the treatment outcome of personality disorders. Method: A literature search of studies pertaining to personality disorder and outcome was conducted, and studies that focused primarily on Axis II were retained. Of these, naturalistic outcome studies were distinguished from those that addressed treatment outcome specifically. The treatment outcome studies were examined in terms of type of treatment intervention, dependent variables, and outcome. Results: Contrary to contemporary assumptions about Axis II, a substantial number of treatment outcome studies were identified. Trends in the assumptions underlying psychosocial and pharmacologic approaches were identified on the basis of dependent variables. Conclusion: There is evidence that effective treatments exist to alleviate symptoms and reduce symptomatic behaviours that accompany personality disorders. What these results hold for the idea of remission from personality disorder is considered.

Style APA, Harvard, Vancouver, ISO itp.

28

Felling, Ryan J., Sahar M. A. Hassanein, Jennifer Armstrong, Luis Aversa, Lori Billinghurst, Neil A. Goldenberg, Jo Ellen Lee, Emily C. Maxwell, Michael J. Noetzel i Warren Lo. "Treatment and outcome of childhood cerebral sinovenous thrombosis". Neurology: Clinical Practice 10, nr 3 (12.09.2019): 232–44. http://dx.doi.org/10.1212/cpj.0000000000000720.

Pełny tekst źródła

Streszczenie:

ObjectiveTo test our hypothesis that anticoagulation is associated with better neurologic outcomes in childhood cerebral sinovenous thrombosis (CSVT), we analyzed treatment and outcomes in a population of 410 children from the International Pediatric Stroke Study (IPSS).MethodsWe included patients enrolled in the IPSS registry with a diagnosis of CSVT at age >28 days with radiologic confirmation, in isolation or with concomitant arterial ischemic stroke. The primary outcome was the neurologic status at discharge. We defined unfavorable outcome as severe neurologic impairment or death at discharge. The Pediatric Stroke Outcome Measure was used for long-term outcome in those with follow-up. Predictors of anticoagulation use and outcome were analyzed by logistic regression.ResultsMost children (95%) had identifiable risk factors, and 82% received anticoagulation. Shift analysis demonstrated better outcomes at discharge in children who were anticoagulated, and this persisted with longer-term outcomes. In multivariable analysis, anticoagulation was significantly associated with favorable outcomes (adjusted odds ratio [aOR] unfavorable 0.32, p = 0.007) whereas infarct was associated with unfavorable outcome (aOR unfavorable 6.71, p < 0.001). The trauma/intracranial surgery was associated with a lower odds of anticoagulation use (aOR 0.14, p < 0.001).ConclusionsWithin the IPSS registry, children with risk factors of trauma or intracranial surgery were less likely to receive anticoagulation for CSVT. Anticoagulation was associated with a lower odds of severe neurologic impairment or death at hospital discharge, but this finding is limited and needs further confirmation in randomized, controlled, prospective studies.

Style APA, Harvard, Vancouver, ISO itp.

29

Harrison, Patricia A., i Stephen E. Asche. "Adolescent Treatment for Substance Use Disorders: Outcomes and Outcome Predictors". Journal of Child & Adolescent Substance Abuse 11, nr 2 (grudzień 2001): 1–17. http://dx.doi.org/10.1300/j029v11n02_01.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Taylor, Rachael W., Lindsey Marwood, Ben Greer, Rebecca Strawbridge i Anthony J. Cleare. "Predictors of response to augmentation treatment in patients with treatment-resistant depression: A systematic review". Journal of Psychopharmacology 33, nr 11 (17.09.2019): 1323–39. http://dx.doi.org/10.1177/0269881119872194.

Pełny tekst źródła

Streszczenie:

Background: Treatment-resistant depression is an important contributor to the global burden of depression. Antidepressant augmentation is a recommended treatment strategy for treatment-resistant patients, but outcomes remain poor. Identifying factors that are predictive of response to augmentation treatments may improve outcomes. Aims: This review aimed to synthesise the existing literature examining predictors of response to augmentation treatments in patients who had insufficiently responded to initial treatment. Methods: A systematic search was conducted identifying 2241 unique manuscripts. 24 examining predictors of outcome to pharmacological or psychological augmentation treatment were included in this review. Results: Atypical antipsychotics were the most frequently assessed treatment class (nine studies), closely followed by mood stabilisers (eight studies). Only one eligible psychological augmentation study was identified. Early response to treatment (week 2) was the best-supported predictor of subsequent treatment outcome, reported by six studies. Many predictor variables were only assessed by one report and others such as pre-treatment severity yielded contradictory results, both within and across treatment classes. Conclusions: This review highlights the importance of early response as a predictor of pharmacological augmentation outcome, with implications for both the monitoring and treatment of resistant unipolar patients. Further replication is needed across specific interventions to fully assess the generalisability of this finding. However, the clear lack of consistent evidence for other predictive factors both within and across treatments, and the scarce examination of psychological augmentation, demonstrates the need for much more research of a high quality if response prediction is to improve outcomes for patients with treatment-resistant depression.

Style APA, Harvard, Vancouver, ISO itp.

31

Simpson, D. Dwayne, George W. Joe i Barry S. Brown. "Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS)." Psychology of Addictive Behaviors 11, nr 4 (grudzień 1997): 294–307. http://dx.doi.org/10.1037/0893-164x.11.4.294.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Crandal, Brent R., Sharon L. Foster, Jason E. Chapman, Phillippe B. Cunningham, Patricia A. Brennan i Elizabeth A. Whitmore. "Therapist perception of treatment outcome: Evaluating treatment outcomes among youth with antisocial behavior problems." Psychological Assessment 27, nr 2 (czerwiec 2015): 710–25. http://dx.doi.org/10.1037/a0038555.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Ospel, JM, A. Ganesh, M. Kappelhof, R. McDonough, R. Nogueira, R. McTaggart, B. Menon i in. "P.136 Evaluating outcome prediction models in endovascular treatment for acute ischemic stroke using baseline, treatment and post-treatment variables". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 48, s3 (listopad 2021): S58. http://dx.doi.org/10.1017/cjn.2021.412.

Pełny tekst źródła

Streszczenie:

Background: Predicting outcomes after endovascular treatment (EVT) for acute ischemic stroke with baseline variables remains a challenge. We assessed the performance of stroke outcome prediction models for EVT in acute ischemic stroke in an iterative fashion using baseline, treatment-related and post-treatment variables. Methods: Data from the ESCAPE-NA1 trial were used to build 4 outcome prediction models using multi-variable logistic regression: Model 1 included baseline variables only that are available prior to treatment decision-making, model 2 included additional treatment-related variables, model 3 additional early post-treatment variables, and model 4 additional late post-treatment variables. The primary outcome was 90-day modified Rankin Scale score 0-2. Model performance was compared using the area under the curve (AUC). Results: Among 1,105 patients, good outcome was achieved by 666 (60.3%). When using baseline variables only (model 1), the AUC was 0.74 (95%CI:0.71-0.77); this iteratively improved when treatment and post-treatment variables were added to the models (model 2: AUC 0.77,95%CI: 0.74-0.80, model 3: AUC 0.80,95%CI:0.77-0.83, model 4: AUC 0.82, 95%CI:0.79-0.85). Conclusions: Predicting EVT outcomes using baseline variables alone is inaccurate in one in four patients, and may be inappropriate for patient selection. Even the most comprehensive models with treatment-related and post-treatment factors involve considerable uncertainty.

Style APA, Harvard, Vancouver, ISO itp.

34

Stimmel, Glen L. "Maximizing Treatment Outcome in Depression". Disease Management and Health Outcomes 9, nr 4 (2001): 179–86. http://dx.doi.org/10.2165/00115677-200109040-00001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Lind, E., O. Fausa, E. Gjone i S. B. Mogensen. "Crohn's Disease: Treatment and Outcome". Scandinavian Journal of Gastroenterology 20, nr 8 (styczeń 1985): 1014–18. http://dx.doi.org/10.3109/00365528509088864.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Ohbu, Sadayoshi. "Re-examination of Treatment Outcome". Nihon Naika Gakkai Zasshi 96, nr 6 (2007): 1247–48. http://dx.doi.org/10.2169/naika.96.1247.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Mohammad, Akikur, Kristopher J. Irizarry, Rebecca Ninah Shub i Alexandria Sarkar. "Addiction Treatment Aftercare Outcome Study". Open Journal of Psychiatry 07, nr 01 (2017): 51–60. http://dx.doi.org/10.4236/ojpsych.2017.71005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Gaikwad, Deepali, S. S. Gaikwad i Snigdha Thakur. "Treatment outcome of tuberculous lymphadeniti". International Journal of Recent Scientific Research 8, nr 03 (28.03.2017): 15809–12. http://dx.doi.org/10.24327/ijrsr.2017.0803.0008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Iványi, János László, Éva Marton i Márk Plander. "Treatment outcome of immune thrombocytopenia". Orvosi Hetilap 153, nr 41 (październik 2012): 1613–21. http://dx.doi.org/10.1556/oh.2012.29456.

Pełny tekst źródła

Streszczenie:

Introduction: Treatment of immune thrombocytopenia is sometimes difficult and needs personal setting. According to evidence-based guidelines, corticosteroids are suggested for first-line treatment. In case of corticosteroid ineffectiveness, second-line therapeutic options (splenectomy, immunosuppressive drugs and, recently, thrombopoietin-mimetics) may result in beneficial therapeutic effect. Aims: The aim of the authors was to examine the clinicopathological data, disease course, treatment results, and the effectiveness of novel drugs in patients with immune thrombocytopenia. Patients and methods: The authors retrospectively analysed the files of 79 immune thrombocytopenic patients (26 males and 53 females) diagnosed and treated at the hematologic in- and outpatient units of the Markusovszky Hospital, County Vas, Hungary between January 1, 2000 and December 31, 2011. Remission rates, disease-free and overall survivals in response to corticosteroids (first-line treatment), after splenectomy (in cases when corticosteroids proved to be ineffective) and following second-line treatment were analysed. Survival curves were constructed using statistical software programs. Results: Of the 79 patients during a median follow-up of 66 months (min. 3, max. 144 months), 28 patients receiving first-line corticosteroids achieved complete remission and remained in a prolonged disease-free condition (35.4%; median disease-free survival 75.5 months; min. 2, max. 140 months). Thirty-eight patients underwent splenectomy after ineffective treatment with corticosteroids or other immunosuppressive (48.0%; median disease-free survival 94.2 months; min. 6, max. 136 months). Surgical complications occurred in 2 cases, while postoperative and late infections were absent. Five patients died but death was not related to immune thrombocytemia. Second-line treatment was applied in 13 patients (16.4%) and among these patients relapse of immune thrombocytopenia after splenectomy was observed in 6 patients. Favourable effects of both conventional (immunosuppressive) and novel treatments (rituximab, thrombopoietin-mimetics) were also detected. Conclusions: More than two-thirds of patients with immune thrombocytopenia responded to corticosteroids or to splenectomy and achieved prolonged disease-free remission. Novel drugs (rituximab, thrombopoietin-mimetics) applied only in few cases produced also favourable results in patients not responding to corticosteroids and splenectomy. Orv. Hetil., 2012, 153, 1613–1621.

Style APA, Harvard, Vancouver, ISO itp.

40

Pan, Ay-Woan, i Li-Ting Liu. "Therapeutic Relationship and Treatment Outcome". American Journal of Occupational Therapy 70, nr 4_Supplement_1 (1.08.2016): 7011510234p1. http://dx.doi.org/10.5014/ajot.2016.70s1-po7019.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Feldmann, Ingalill. "Satisfaction with orthodontic treatment outcome". Angle Orthodontist 84, nr 4 (lipiec 2014): 581–87. http://dx.doi.org/10.2319/093013-710.1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Finlay, Andrew Y., i Kristian Reich. "Outcome assessment and treatment goals". Expert Review of Dermatology 3, sup1 (sierpień 2008): S39—S40. http://dx.doi.org/10.1586/17469872.3.4s.s39.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Millichap, J. Gordon. "Congenital Toxoplasmosis: Treatment and Outcome". Pediatric Neurology Briefs 9, nr 1 (1.01.1995): 7. http://dx.doi.org/10.15844/pedneurbriefs-9-1-11.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Mikhail, Sameh, i Tanios Bekaii-Saab. "RASmutations: impact on treatment outcome". Colorectal Cancer 2, nr 6 (grudzień 2013): 525–34. http://dx.doi.org/10.2217/crc.13.63.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Garg, Prashant, Umang Mathur, Sreedharan Athmanathan i Gullapalli N. Rao. "Treatment Outcome of Moraxella Keratitis". Cornea 18, nr 2 (marzec 1999): 176. http://dx.doi.org/10.1097/00003226-199903000-00006.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Wan, Michelle, Reid Finlayson i Arran Rowles. "Sexual Dependency Treatment Outcome Study". Sexual Addiction & Compulsivity 7, nr 3 (lipiec 2000): 177–96. http://dx.doi.org/10.1080/10720160008400217.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Tijssen, J. G. P., H. J. J. Kerkkamp, J. W. Viersma, J. M. De Beijer, P. J. De Feijter i J. Lubsen. "Treatment, observations, and outcome events". European Heart Journal 8, suppl H (2.10.1987): 35–48. http://dx.doi.org/10.1093/eurheartj/8.suppl_h.35.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Ozaki, T., M. Hamada, S. Sugihara, T. Kunisada, S. Mitani i H. Inoue. "Treatment Outcome of Osteofibrous Dysplasia". Journal of Pediatric Orthopaedics B 7, nr 3 (lipiec 1998): 199–202. http://dx.doi.org/10.1097/01202412-199807000-00004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Rovet, Joanne. "Congenital hypothyroidism: treatment and outcome". Current Opinion in Endocrinology & Diabetes 12, nr 1 (luty 2005): 42–52. http://dx.doi.org/10.1097/01.med.0000152669.91427.73.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Fouda, Mona. "MAXILLARY SINUS CARCINOMA: TREATMENT OUTCOME". Research in Oncology 5, Issue 1-2 (1.01.2009): 13–17. http://dx.doi.org/10.21608/resoncol.2009.401.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!